Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 367-372, March 2010

Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study–CVD

  • Lin Xu

      Affiliations

    • Guangzhou No. 12 Hospital, Guangzhou, China
    • Department of Community Medicine and School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong, China
  • ,
  • Chao Qiang Jiang

      Affiliations

    • Guangzhou No. 12 Hospital, Guangzhou, China
  • ,
  • Tai Hing Lam

      Affiliations

    • Department of Community Medicine and School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong, China
    • Corresponding Author InformationCorresponding author. Tel: +852 2819 9287; fax: +852 2855 9528.
  • ,
  • Kar Keung Cheng

      Affiliations

    • Public Health, Epidemiology, and Biostatistics, University of Birmingham, Birmingham, UK
  • ,
  • Xiao Jun Yue

      Affiliations

    • Guangzhou No. 12 Hospital, Guangzhou, China
  • ,
  • Jie Ming Lin

      Affiliations

    • Guangzhou No. 12 Hospital, Guangzhou, China
  • ,
  • Wei Sen Zhang

      Affiliations

    • Guangzhou No. 12 Hospital, Guangzhou, China
  • ,
  • G. Neil Thomas

      Affiliations

    • Public Health, Epidemiology, and Biostatistics, University of Birmingham, Birmingham, UK

Received 18 June 2009; accepted 4 August 2009. published online 14 October 2009.

Abstract 

The aim of the study was to compare the impact of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) on vascular function among older Chinese people. A random sample of 671 men and 603 women aged 50 to 85 years without known diabetes from the Guangzhou Biobank Study–CVD was examined in a cross-sectional study. Subjects with no previously confirmed or treated diabetes but with both fasting plasma glucose less than 5.6 mmol/L and 2-hour glucose from 7.8 to less than 11.0 mmol/L were classified as having isolated IGT, and those with no previously confirmed and treated diabetes but with both fasting plasma glucose from 5.6 to less than 7.0 mmol/L and 2-hour glucose less than 7.8 mmol/L were classified as having isolated IFG. A total of 11.0% of the men and 8.6% of the women had isolated IFG, and 17.7% of the men and 18.6% of the women had isolated IGT. The brachial-ankle pulse wave velocity and pulse pressure were increased in both the isolated IFG and isolated IGT subjects compared with the normoglycemia group (both Ps < .001). Compared with subjects with isolated IFG, those with isolated IGT appeared to have a higher age- and sex-adjusted brachial-ankle pulse wave velocity (1543 ± 22 vs 1566 ± 17, P = .07) and to be more insulin resistant (2-hour postload insulin: 54.2 ± 2.13 vs 26.8 ± 2.99 μU/mL, P < .001), had a worse lipid profile (apolipoprotein [apo] B: 1.07 ± 0.02 vs 0.97 ± 0.02g/L, P < .001; apo B/apo A-1 ratio: 0.80 ± 0.02 vs 0.69 ± 0.02, P < .001), but had lower glycosylated hemoglobin levels (6.03% ± 0.06% vs 5.86% ± 0.04%, P < .001) (values are mean ± SE). Subjects with isolated IGT had greater arterial stiffness, probably as a result of being more insulin resistant, with a worse lipid profile than those with isolated IFG. The sole use of fasting glucose level to identify prediabetic people would fail to identify a significant proportion of the at-risk population.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(09)00328-X

doi:10.1016/j.metabol.2009.08.004

Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 367-372, March 2010